[2019 international oncology news: A compendium]

Nicolas Magné¹, Renaud Sabatier², Marie Wislez³

¹Institut de cancérologie Lucien Neuwirth, département universitaire de la recherche et de l'enseignement, département de radiothérapie, 108, bis, avenue Albert-Raimond, BP 60008, 42270 Saint-Priest-en-Jarez cedex, France; Institut de physique nucléaire de Lyon (IPNL), faculté de médecine Lyon-Sud, radiobiologie cellulaire et moléculaire, UMR 5822, 69622 Villeurbanne, France.

|February 15, 2020

Abstract:

Over the past years, planet oncology has kept changing and moving forward. Recent results of important clinical trials are challenging our daily practices. With modesty, the Editorial Board of BulletinduCancer has selected some clinical trials they consider as "must-know about" even if they go beyond our medical fields.

Keywords:

Breast cancer Cancers broncho-pulmonaires Cancers de la prostate Cancers de primitifs inconnus Cancers digestifs Cancers du sein Cancers gynécologiques Digestive cancer Gynaecological cancer Lung cancer Palliative care Prostate cancer Soins palliatifs Unknown primary cancer

Related Experiment Videos

[2019 international oncology news: A compendium]

Related Concept Videos

Hemophagocytic lymphohistiocytosis-like syndrome after CD19-directed CAR T-cells for B-cell lymphoma and B-cell acute lymphoblastic leukemia: A LYSA, SFCE, and GRAALL study from the DESCAR-T registry.

Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm.

Prolonged survival with glofitamab in non-diffuse large B-cell lymphoma after CAR T-cell therapy relapse.

Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.

Health-related quality of life after second-line axi-cel in transplant-ineligible patients with large B-cell lymphoma.

Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma.

[Gynecological cancer surgery: Is robotic surgery an advantage over conventional laparoscopy?]

[Management of chronic pulmonary GVH in 2025, indication for lung transplantation (SFGM-TC)].

[Guidelines for the essential data entry in the European Bone Marrow Transplant Registry].

[Sexual and reproductive life of men and women with chronic myeloid leukemia: Opinion and practical considerations of the Fi-LMC group].

[Transoral robotic surgery in head and neck cancers].

[Who refer patients with multiple myeloma to hematology-oncology: A retrospective study at Hôtel-Dieu de France].

Systems genetics analysis reveals immune mediators of coronavirus disease severity in mice.

Molecular clusters and precision medicine in pheochromocytomas and paragangliomas.

Short-term outcomes of a randomized, mixed-methods trial to improve hereditary cancer test results disclosure and follow-up communication with family.

Genetic associations and candidate functional genes linking depression and obesity: a multi-omics integrative study.

Multi-Site Aggregation of p53: Insights from Self- and Co-Aggregation of Multiple Aggregation-Prone Regions.

Sex differences in the pathogenesis of degenerative knee osteoarthritis: a comparative transcriptomics analysis.

Related Experiment Videos

[2019 international oncology news: A compendium]

Abstract:

Related Concept Videos

Related Articles